Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 14,932 | 17,902 | 18,110 | 17,046 | 12,974 |
| Operating Income | -14,932 | -17,902 | -18,110 | -17,046 | -12,974 |
| Other Income | 2,140 | 1,862 | 2,120 | 2,481 | 2,707 |
| Pre-tax Income | -12,792 | -16,040 | -15,990 | -14,565 | -10,267 |
| Net Income Continuous | -12,792 | -16,040 | -15,990 | -14,565 | -10,267 |
| Net Income | $-12,792 | $-16,040 | $-15,990 | $-14,565 | $-10,267 |
| EPS Basic Total Ops | -0.45 | -0.62 | -0.62 | 2.16 | -0.40 |
| EPS Basic Continuous Ops | -0.46 | -0.62 | -0.62 | 2.15 | -0.40 |
| EPS Diluted Total Ops | -0.45 | -0.62 | -0.62 | 2.16 | -0.40 |
| EPS Diluted Continuous Ops | -0.46 | -0.62 | -0.62 | 2.15 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.62 | -0.62 | -0.56 | -0.40 |
| EBITDA(a) | $-14,851 | $-17,823 | $-18,032 | $-16,971 | $-12,912 |